Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-06-20
2009-11-24
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S236100, C424S009100, C435S068100, C435S069100, C435S070100, C435S320100, C435S252300, C435S325000, C530S350000, C530S412000, C514S002600, C514S012200, C536S023100
Reexamination Certificate
active
07622127
ABSTRACT:
Agents for treating pain, methods for producing the agents and methods for treating pain by administration to a patient of a therapeutically effective amount of the agent. The agent can include aclostridialneurotoxin, or a component or fragment or derivative thereof, attached to a targeting moiety, wherein the targeting moiety is selected from a group consisting of transmission compounds which can be released from neurons upon the transmission of pain signals by the neurons, and compounds substantially similar to the transmission compounds.
REFERENCES:
patent: 4189426 (1980-02-01), Li
patent: 4481139 (1984-11-01), Folkers et al.
patent: 4664911 (1987-05-01), Uhr et al.
patent: 4719231 (1988-01-01), Umezawa et al.
patent: 5410019 (1995-04-01), Coy et al.
patent: 5714468 (1998-02-01), Binder
patent: 5744131 (1998-04-01), Edwards et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 5846216 (1998-12-01), Gonzales et al.
patent: 5861284 (1999-01-01), Nishimura et al.
patent: 5891842 (1999-04-01), Kream
patent: 5965406 (1999-10-01), Murphy
patent: 5989545 (1999-11-01), Foster et al.
patent: 6395513 (2002-05-01), Foster et al.
patent: 6500436 (2002-12-01), Donovan
patent: 6632440 (2003-10-01), Quinn et al.
patent: 6641820 (2003-11-01), Donovan
patent: 7022329 (2006-04-01), Donovan
patent: 7052702 (2006-05-01), Duggan et al.
patent: 7056729 (2006-06-01), Donovan
patent: 7132259 (2006-11-01), Dolly et al.
patent: 7138127 (2006-11-01), Donovan
patent: 7192596 (2007-03-01), Shone et al.
patent: 7244436 (2007-07-01), Donovan
patent: 7244437 (2007-07-01), Donovan
patent: 7262291 (2007-08-01), Donovan
patent: 7413742 (2008-08-01), Donovan
patent: 7419676 (2008-09-01), Dolly et al.
patent: 7422877 (2008-09-01), Dolly et al.
patent: 7425338 (2008-09-01), Donovan
patent: 2003/0180289 (2003-09-01), Foster et al.
patent: 2004/0071736 (2004-04-01), Quinn et al.
patent: 2006/0078571 (2006-04-01), Donovan
patent: 2008/0032930 (2008-02-01), Steward et al.
patent: 2008/0032931 (2008-02-01), Steward et al.
patent: 2008/0081355 (2008-04-01), Dolly et al.
patent: 2008/0161226 (2008-07-01), Steward et al.
patent: 2008/0161543 (2008-07-01), Steward et al.
patent: 2008/0182294 (2008-07-01), Dolly et al.
patent: 2008/0213311 (2008-09-01), Donovan
patent: 2008/0311622 (2008-12-01), Dolly et al.
patent: 2008/0317782 (2008-12-01), Donovan
patent: 2008/0317783 (2008-12-01), Donovan
patent: 2009/0004224 (2009-01-01), Steward et al.
patent: 2009/0005313 (2009-01-01), Steward et al.
patent: 2009/0010967 (2009-01-01), Donovan
patent: 2009/0017071 (2009-01-01), Donovan
patent: 2009/0018081 (2009-01-01), Steward et al.
patent: 2009/0028908 (2009-01-01), Donovan
patent: 2009/0030182 (2009-01-01), Dolly et al.
patent: 2009/0030188 (2009-01-01), Dolly et al.
patent: 2009/0042270 (2009-02-01), Dolly et al.
patent: 2009/0042799 (2009-02-01), Donovan
patent: 2009/0069238 (2009-03-01), Steward et al.
patent: 2009/0081730 (2009-03-01), Dolly et al.
patent: 2009/0087458 (2009-04-01), Dolly et al.
patent: WO 94/21300 (1994-09-01), None
patent: 9532738 (1995-07-01), None
patent: 9633273 (1996-10-01), None
patent: 9801754 (1998-01-01), None
patent: 9807864 (1998-02-01), None
patent: 9917806 (1999-04-01), None
patent: WO 2004/024909 (2004-03-01), None
patent: WO 2005/023309 (2005-03-01), None
patent: WO 2006/027207 (2006-03-01), None
patent: WO 2006/059093 (2006-06-01), None
patent: WO 2006/059105 (2006-06-01), None
patent: WO2006/059113 (2006-06-01), None
XP-00857076, Mosaic Structres of Neurotoxins Produced fromClostridium botulinumtypes C and D organisms, Morishi et al, Biochimca et Biophysica Acta, 1307 (1996) 123-126.
XP001011356, Berge, O-G et al, Selective Neurotoxic Lesions of Descending Serotonergic and Noadrenergic Pathways in the Rat, Journal of Neurochemistry; 44(4):1156-1161(1985).
XP001012206, Benoliel, R et al, Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain, Pain; 79(2-3):243-253(1999).
XP001011386, Garzon, J et al, Effect of intrathecal injection of pertusis toxin on substance P norepinephrine and serotonin contents in various neural structures of arthritic rats; Life Sciences; 47(21);1915-1924(1990).
Herreros et al, “C-Terminal Half of Tetanus Toxin Fragment C is Sufficient for Neuronal Binding and Interaction with a Putative Protein Receptor”, Biochemical Journal, vol. 347, No. Part 1, pp. 199-204, Apr. 1, 2001.
Rummel et al, “The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interation”, Molecular Microbiology, pp. 631-643, Dec. 15, 2003.
Halpern et al, “Characterization of the receptor-binding domain of tetanus toxin”, Journal of Biological Chemistry, pp. 11188-11192, May 25, 1993.
Allergan Inc.
Condino Debra D.
German Joel B.
Kam Chih-Min
Stathakis Dean G.
LandOfFree
Clostridial toxin derivatives and methods for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clostridial toxin derivatives and methods for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clostridial toxin derivatives and methods for treating pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4138800